W Ward

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in Type 1 diabetes
    W K Ward
    Legacy Health System, Legacy Research Institute, Portland, OR 97232, USA
    Diabet Med 29:1067-73. 2012
  2. ncbi Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia
    W Kenneth Ward
    Oregon Health and Science University, Portland, Oregon 97239, USA
    J Diabetes Sci Technol 5:1373-80. 2011
  3. ncbi In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effect
    W Kenneth Ward
    Legacy Health System Research, Portland, Oregon 97232, USA
    J Diabetes Sci Technol 4:1311-21. 2010

Research Grants

  1. Assesment of a Chronic Subcutaneous Glucose Sensor
    W Ward; Fiscal Year: 2003
  2. Passivating Proteins in Implantable Glucose Sensors
    W Ward; Fiscal Year: 2004

Collaborators

Detail Information

Publications3

  1. ncbi The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in Type 1 diabetes
    W K Ward
    Legacy Health System, Legacy Research Institute, Portland, OR 97232, USA
    Diabet Med 29:1067-73. 2012
    ..It is unclear whether the magnitude of sensor lag is lower during falling glucose than during rising glucose...
  2. ncbi Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia
    W Kenneth Ward
    Oregon Health and Science University, Portland, Oregon 97239, USA
    J Diabetes Sci Technol 5:1373-80. 2011
    ..Elements such as the use of glucagon to minimize hypoglycemia, adaptation to changes in insulin sensitivity, and sensor redundancy will likely increase safety during outpatient use of closed-loop glycemic control systems...
  3. ncbi In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effect
    W Kenneth Ward
    Legacy Health System Research, Portland, Oregon 97232, USA
    J Diabetes Sci Technol 4:1311-21. 2010
    ..However, under some conditions, solutions of glucagon can form amyloid fibrils. Currently, the usage instructions for commercially available glucagon allow only for its immediate use...

Research Grants5

  1. Assesment of a Chronic Subcutaneous Glucose Sensor
    W Ward; Fiscal Year: 2003
    ..ether-based polymer. We will compare their long term function in studies using rabbits, which will be also be used to ascertain the effect of the growth factors and the real-time data processing. ..
  2. Passivating Proteins in Implantable Glucose Sensors
    W Ward; Fiscal Year: 2004
    ..8. A histologic evaluation will be performed to assess the effect of passivating proteins and antibody blocked fibrinogen on the nature of the foreign body capsule. ..